Circulating Tumor DNA Testing in Predicting Treatment for Patients With Stage IIA Colon Cancer After Surgery
NRG Oncology
NRG Oncology
Tempus AI
Federation Francophone de Cancerologie Digestive
Peking University Cancer Hospital & Institute
Stanford University
NSABP Foundation Inc